Your browser doesn't support javascript.
loading
Chemotherapy combined with Endostar as salvage treatment for EGFR-tyrosine kinase inhibitor primary resistance in an advanced non-small cell lung cancer patient with EGFR L858R mutation and ROS1 fusion: A case report.
Qiu, Dong; Zhang, Yu; Xue, Ying-Bo; Shen, Qi; Li, Hang; Huang, Ping; Hu, Jian-Jun; Wang, Yong-Sheng.
Afiliação
  • Qiu D; Department of Thoracic Oncology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu, China.
  • Zhang Y; Department of Oncology, Guizhou People's Hospital, Guiyang, China.
  • Xue YB; Department of Oncology, Guizhou People's Hospital, Guiyang, China.
  • Shen Q; Department of Oncology, Guizhou People's Hospital, Guiyang, China.
  • Li H; Department of Oncology, Guizhou People's Hospital, Guiyang, China.
  • Huang P; Department of Oncology, Guizhou People's Hospital, Guiyang, China.
  • Hu JJ; Department of Pathology, Guizhou People's Hospital, Guiyang, China.
  • Wang YS; Department of Pathology, Guizhou People's Hospital, Guiyang, China.
Thorac Cancer ; 10(4): 1023-1028, 2019 04.
Article em En | MEDLINE | ID: mdl-30775851

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Tirosina Quinases / Proteínas Recombinantes / Proteínas Proto-Oncogênicas / Carcinoma Pulmonar de Células não Pequenas / Endostatinas / Tratamento Farmacológico / Neoplasias Pulmonares Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Tirosina Quinases / Proteínas Recombinantes / Proteínas Proto-Oncogênicas / Carcinoma Pulmonar de Células não Pequenas / Endostatinas / Tratamento Farmacológico / Neoplasias Pulmonares Idioma: En Ano de publicação: 2019 Tipo de documento: Article